{"id":49028,"date":"2022-09-30T15:01:58","date_gmt":"2022-09-30T13:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-companion-diagnostics-market-2022-2028-ongoing-research-and-investments-in-next-generation-gene-sequencing-presents-opportunities-researchandmarkets-com\/"},"modified":"2022-09-30T15:01:58","modified_gmt":"2022-09-30T13:01:58","slug":"global-companion-diagnostics-market-2022-2028-ongoing-research-and-investments-in-next-generation-gene-sequencing-presents-opportunities-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-companion-diagnostics-market-2022-2028-ongoing-research-and-investments-in-next-generation-gene-sequencing-presents-opportunities-researchandmarkets-com\/","title":{"rendered":"Global Companion Diagnostics Market 2022-2028: Ongoing Research and Investments in Next Generation Gene-Sequencing Presents Opportunities – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Companion Diagnostics Market 2022-2028”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nMarket Outlook<\/strong>\n<\/p>\n

\nBased on this report, the global companion diagnostics market is projected to progress with a CAGR of 12.84% during the forecast period 2022-2028.\n<\/p>\n

\nThe prominent factors fueling the global market’s growth include a surge in medication reaction incidence, increasing cancer cases, and the growing use of precision medicines. Additionally, the ongoing research and investments in next generation gene-sequencing are expected to create affluent opportunities for the market.\n<\/p>\n

\nHowever, a weak reimbursement framework and common cases of leakage in oncology companion diagnostics are expected to restrict the studied market’s growth over the forecast period.\n<\/p>\n

\nRegional Outlook<\/strong>\n<\/p>\n

\nThe global companion diagnostics market covers North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.\n<\/p>\n

\nThe Asia-Pacific is anticipated to emerge as the fastest-growing region over the forecast period. The region’s growth can be attributed to the tremendous growth in precision medicine technology. Moreover, initiatives undertaken to promote the R&D of precision medicine are supporting the market’s growth. In this regard, diagnostic and pharma companies are collaborating to offer an international platform to facilitate access to precision medicine. Thus, as mentioned above, these factors are expected to widen the scope and growth of the companion diagnostics market in the upcoming years.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nMarket Drivers\n<\/p>\n